All Comments by Dave Morgan

  1. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
  2. Smuggling Antibodies to BACE Across the Blood-Brain Barrier
  3. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
  4. Piping in Passive Immunization Spares Blood Vessels
  5. Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy.
  6. Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
  7. Complement: AD Friend or Foe? New Work Tips Balance to Former
  8. AD Immunotherapy: Toward Prevention, DNA-based Vaccines?
  9. A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
  10. Incidence and prognosis of transient neurological attacks.
  11. Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.
  12. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.
  13. San Diego: Treating Forgetfulness—Triple Transgenics Provoke
  14. Tackling Alzheimer’s from the Outside In
  15. Primate Model Promising for Studying Aβ Vaccine